PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
16-Sep-2024 Certa Therapeutics Announces International Non-Proprietary Name for its First-in-class GPR68 Inhibitor Asengeprast (FT011) Certa Therapeutics
16-Sep-2024 Inauguration of the New Richter BioLogics cGMP Facility for the Manufacture of Biopharmaceuticals for the Global Market Richter BioLogics GmbH & Co KG
16-Sep-2024 China patent notification boosts PolTREG’s development of Treg cell therapy in multiple sclerosis PolTREG
16-Sep-2024 Transgene and BioInvent’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments Transgene
13-Sep-2024 Optalitix secures further $3m led by Calculus Capital to accelerate ambitious growth strategy Optalitix
13-Sep-2024 Cytovation to present full safety and efficacy data from the CICILIA Phase I/IIa trial evaluating CY-101 in solid tumors at ESMO 2024 Cytovation ASA
13-Sep-2024 Clinical Research Training: Your Path to a Successful Career Fusion technology solutions
12-Sep-2024 Gilead’s Twice-Yearly Lenacapavir for HIV Prevention Reduced HIV Infections by 96% and Demonstrated Superiority to Daily Truvada® in Second Pivotal Phase 3 Trial Gilead’s
12-Sep-2024 Biocomposites to distribute its NanoBone® product range in the UK Biocomposites
12-Sep-2024 Epitopea Awarded Grant from Innovate UK’s Cancer Therapeutics Programme Epitopea
12-Sep-2024 KADANS SCIENCE PARTNER WELCOMES NEW TENANT MYRICX BIO TO LONDON INNOVATION CENTRE AT CANARY WHARF Kadans Science Partner
12-Sep-2024 Arctoris acquires Eli Lilly ‘Life Science Studio’ laboratory Arctoris
12-Sep-2024 Vapourtec invests in future with Bristol CDT partnership Vapourtec
12-Sep-2024 QL Biopharm Presented Results from Phase 1c Clinical Study on its Novel Once-Monthly GLP-1RA ZT002 at EASD 2024 Beijing QL Biopharmaceutical Co., Ltd
12-Sep-2024 Choosing the Right Clinical Research Institute: A Step-by-Step Guide with Fusion Technology Solutions Fusion technology solutions
11-Sep-2024 MHRA authorization of Dupixent (dupilumab) marks a significant step forward as the UK moves closer to the first ever targeted biologic for the treatment of uncontrolled COPD Sanofi
11-Sep-2024 Nxera Pharma’s Partner Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers Nxera Pharma
11-Sep-2024 Anthony Nolan to open stem cell collection centre to help patients and enable cell and gene therapy research Stem cell charity Anthony Nolan
11-Sep-2024 LinkGevity Secures Place in Prestigious SPACE-H Accelerator Program LinkGevity
11-Sep-2024 EORTC Extends Medidata Partnership to Help Power New Phased of Oncology Research EORTC